ACADIAN ASSET MANAGEMENT LLC - DIFFUSION PHARMACEUTICALS IN ownership

DIFFUSION PHARMACEUTICALS IN's ticker is and the CUSIP is 253748305. A total of 22 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of DIFFUSION PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$119,000
+4.4%
378,712
+52.5%
0.00%0.0%
Q4 2019$114,000
+256.2%
248,311
+1360.0%
0.00%
Q3 2019$32,000
-33.3%
17,0080.0%0.00%
Q2 2019$48,00017,0080.00%
Other shareholders
DIFFUSION PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
Yu Fan 269,544$213,0000.35%
Southland Equity Partners LLC 12,030$9,5640.01%
Sugarloaf Wealth Management, LLC 15,750$13,0000.00%
Frontier Wealth Management LLC 25,000$20,0000.00%
Renaissance Technologies 2,832,739$2,252,0000.00%
UBS Group AG 5,999$5,0000.00%
IFP Advisors, Inc 0$00.00%
Squarepoint Ops LLC 17,984$14,0000.00%
TWO SIGMA INVESTMENTS, LP 106,341$85,0000.00%
OSAIC HOLDINGS, INC. 29,477$24,0000.00%
View complete list of DIFFUSION PHARMACEUTICALS IN shareholders